Regulatory Compliance
AlloSource takes great pride in being an industry leader with regard to regulatory compliance. As one of the nation's largest non-profit providers of bone, skin and soft tissue allografts, AlloSource maintains a Quality Assurance program in compliance with applicable federal and state regulations as well as voluntary standards.
The Food and Drug Administration (FDA) has produced several guidelines, final rules and proposed rules for the tissue banking industry, addressing tissue intended for transplantation, donor, suitability, good tissue practices, facility inspections, regulation enforcement and establishment registration. AlloSource not only supports regulation, but also works closely with the FDA to continuously improve industry guidelines.